| 1. | Buprenorphine Tapering Schedule and Illicit Opioid Use.  |
| | Ling, Walter ; Hillhouse, Maureen ; Domier, Catherine ; Doraimani, Geetha ; Hunter, Jeremy ; Thomas, Christie ; Jenkins, Jessica ; Hasson, Albert ; Annon, Jeffrey J. ; Saxon, Andrew J. ; Selzer, Jeffrey A. ; Boverman, Joshua ; Bilangi, Richard |
| | Addiction 2009;104(2):256-265 [doi: 10.1111/j.1360-0443.2008.02455.x]. |
| | |
| |
| 2. | Research Network Involvement and Addiction Treatment Center Staff: Counselor Attitudes toward Buprenorphine. |
| | Knudsen, Hannah K. ; Ducharme, Lori J. ; Roman, Paul M. |
| | American Journal on Addictions 2007;16(5):365-371 [doi: 10.1080/10550490701525418]. |
| | |
| |
| 3. | Innovation Adoption in Substance Abuse Treatment: Exposure, Trialability, and the Clinical Trials Network. |
| | Ducharme, Lori J. ; Knudsen, Hannah K. ; Roman, Paul M. ; Johnson, J. Aaron |
| | Journal of Substance Abuse Treatment 2007;32:321-329. [doi: 10.1016/j.jsat.2006.05.021]. |
| | |
| |
| 4. | Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules. Should I Join?  |
| | NIDA Center for the Clinical Trials Network (NIDA CCTN) |
| | |
| | |
| |